22 Sep 2016 14:15
PuriCore plc
("PuriCore" or the "Company")
Grant of Options
22 September 2016 - PuriCore plc (AIM: PURI), announces the grant of share options to Dr. Christian Peters, Chief Medical Officer, to subscribe for up to 500,000 new ordinary shares of 10p each in the capital of the Company (the "Options").
The Options, granted on 21 September 2016, have an exercise price of 27.00 pence each and a five year term. The Options vest one-third per year on each of the three anniversaries of the grant date. Dr. Peters holds no other options over shares in the Company.
Enquiries:
PuriCore plc | +44 (0) 20 3727 1000 |
Alex Martin, Chief Executive Officer Marella Thorell, Chief Financial Officer and Chief Operating Officer | |
FTI Consulting | +44 (0) 20 3727 1000 |
Simon Conway / Mo Noonan | |
N+1 Singer (Nominated Adviser & Broker) | +44 (0) 20 7496 3000 |
Aubrey Powell / Jen Boorer |
About PuriCore
PuriCore is an emerging specialty biopharmaceutical company focused on developing novel immunomodulatory therapies to protect and improve the lives of adults and children. The Company has initiated a drug development program, based upon its proprietary hypochlorous acid technology at high concentrations. The Company believes their formulations have novel immunomodulatory activity with potential application for the treatment of diseases in a number of therapeutic areas such as Dermatology, Ophthalmology and potentially rare diseases. For more details, go to the Company's website: www.puricore.com
1. | Details of the Person Discharging Managerial Responsibility ("PDMR") / person closely associated with them ("PCA") | ||||||
a) | Name | CHRISTIAN PETERS | |||||
2. | Reason for the notification | ||||||
a) | Position /status | CHIEF MEDICAL OFFICER
| |||||
b) | Initial notification / amendment | INITIAL NOTIFICATION | |||||
3. | Details of the Issuer | ||||||
a) | Name | PURICORE PLC
| |||||
b) | LEI code | N/A | |||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||||
a) | Description of the financial instrument, type of instrument Identification code | ORDINARY SHARES IN PURICORE PLC ISIN: GB00B3XBCR18 | |||||
b) | Nature of the transaction | GRANT OF OPTIONS OVER 500,000 SHARES UNDER THE COMPANY'S PuriCore Executive Omnibus Incentive Plan
| |||||
c) | Price(s) and volume(s) |
| |||||
d) | Aggregated information Aggregated volume Price |
N/A
| |||||
e) | Date of the transaction
| 21 SEPTEMBER 2016 | |||||
f) | Place of the transaction | OUTSIDE A TRADING VENUE | |||||
RLM.L (RLM)